158 related articles for article (PubMed ID: 22706443)
1. The effects of extracorporeal photochemotherapy on T cell activation and regulatory mechanisms in patients with systemic sclerosis.
Papp G; Barath S; Szegedi A; Szodoray P; Zeher M
Clin Rheumatol; 2012 Sep; 31(9):1293-9. PubMed ID: 22706443
[TBL] [Abstract][Full Text] [Related]
2. Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression.
Radstake TR; van Bon L; Broen J; Wenink M; Santegoets K; Deng Y; Hussaini A; Simms R; Cruikshank WW; Lafyatis R
PLoS One; 2009 Jun; 4(6):e5981. PubMed ID: 19543397
[TBL] [Abstract][Full Text] [Related]
3. [Immunological monitoring of the efficacy of extracorporeal photopheresis for prevention of kidney transplant rejection].
Faenko AP; Chuksina YY; Zulkarnayev AB; Fedulkina VA; Vatazin AV; Kantaria RO
Urologiia; 2020 Sep; (4):73-78. PubMed ID: 32897018
[TBL] [Abstract][Full Text] [Related]
4. The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study.
Papp G; Horvath IF; Gyimesi E; Barath S; Vegh J; Szodoray P; Zeher M
Immunol Res; 2016 Apr; 64(2):404-11. PubMed ID: 26168768
[TBL] [Abstract][Full Text] [Related]
5. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
6. Photopheresis: Advances and Use in Systemic Sclerosis.
Zhou XA; Choi J
Curr Rheumatol Rep; 2017 Jun; 19(6):31. PubMed ID: 28466383
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
[TBL] [Abstract][Full Text] [Related]
8. Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69.
Gessl A; Waldhäusl W
Clin Immunol Immunopathol; 1998 May; 87(2):168-75. PubMed ID: 9614932
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis.
Papp G; Horvath IF; Barath S; Gyimesi E; Vegh J; Szodoray P; Zeher M
Clin Immunol; 2012 Feb; 142(2):150-9. PubMed ID: 22036269
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cutaneous T cell lymphoma with extracorporeal photopheresis induces Fas-ligand expression on treated T cells, but does not suppress the expression of co-stimulatory molecules on monocytes.
Bladon J; Taylor PC
J Photochem Photobiol B; 2003 Feb; 69(2):129-38. PubMed ID: 12633985
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis.
Gambichler T; Özsoy O; Bui D; Scheel CH; Susok L
J Dermatolog Treat; 2022 Jun; 33(4):1979-1982. PubMed ID: 33944664
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
[TBL] [Abstract][Full Text] [Related]
14. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
Czyz A; Kołacz E; Angerer D; Zawilska K
Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the immunological phenomena and relationship with clinicopathological characteristics of the tumor--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ lymphocytes in squamous cell laryngeal carcinoma. Part II.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):593-603. PubMed ID: 22252753
[TBL] [Abstract][Full Text] [Related]
16. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
17. CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy.
Yacyshyn MB; Poppema S; Berg A; MacLean GD; Reddish MA; Meikle A; Longenecker BM
Int J Cancer; 1995 May; 61(4):470-4. PubMed ID: 7538976
[TBL] [Abstract][Full Text] [Related]
18. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease.
Meier P; Dayer E; Blanc E; Wauters JP
J Am Soc Nephrol; 2002 Jan; 13(1):204-212. PubMed ID: 11752039
[TBL] [Abstract][Full Text] [Related]
19. CD4
Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
[TBL] [Abstract][Full Text] [Related]
20. Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders.
Rodríguez-Muñoz A; Vitales-Noyola M; Ramos-Levi A; Serrano-Somavilla A; González-Amaro R; Marazuela M
Endocrine; 2016 Mar; 51(3):478-89. PubMed ID: 26100786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
